Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar
This study has been completed.
Study NCT01197911   Information provided by Hoffmann-La Roche

First Received on September 8, 2010.   Last Updated on March 27, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy Volunteer
Additional conditions recognized in this trial
Liver Diseases
More general conditions related to this trial
Digestive System Diseases
Interventions listed in this trial
aleglitazar
Sponsors listed in this trial
Hoffmann-La Roche


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services